99 related articles for article (PubMed ID: 20133021)
1. Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
Effenberger K; Breyer S; Schobert R
Eur J Med Chem; 2010 May; 45(5):1947-54. PubMed ID: 20133021
[TBL] [Abstract][Full Text] [Related]
2. Modification of uptake and subcellular distribution of doxorubicin by N-acylhydrazone residues as visualised by intrinsic fluorescence.
Effenberger-Neidnicht K; Breyer S; Mahal K; Sasse F; Schobert R
Cancer Chemother Pharmacol; 2012 Jan; 69(1):85-90. PubMed ID: 21607555
[TBL] [Abstract][Full Text] [Related]
3. Fatty acyl amide derivatives of doxorubicin: synthesis and in vitro anticancer activities.
Chhikara BS; St Jean N; Mandal D; Kumar A; Parang K
Eur J Med Chem; 2011 Jun; 46(6):2037-42. PubMed ID: 21420207
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of thiobenzanilides as anticancer agents.
Hu WP; Yu HS; Chen YR; Tsai YM; Chen YK; Liao CC; Chang LS; Wang JJ
Bioorg Med Chem; 2008 May; 16(9):5295-302. PubMed ID: 18359635
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, structure-activity relationships, and antitumor studies of 2-benzoxazolyl hydrazones derived from alpha-(N)-acyl heteroaromatics.
Easmon J; Pürstinger G; Thies KS; Heinisch G; Hofmann J
J Med Chem; 2006 Oct; 49(21):6343-50. PubMed ID: 17034140
[TBL] [Abstract][Full Text] [Related]
6. Effects of thymoquinone-fatty acid conjugates on cancer cells.
Breyer S; Effenberger K; Schobert R
ChemMedChem; 2009 May; 4(5):761-8. PubMed ID: 19322799
[TBL] [Abstract][Full Text] [Related]
7. New class of potent antitumor acylhydrazone derivatives containing furan.
Cui Z; Li Y; Ling Y; Huang J; Cui J; Wang R; Yang X
Eur J Med Chem; 2010 Dec; 45(12):5576-84. PubMed ID: 20884091
[TBL] [Abstract][Full Text] [Related]
8. An essential oil and its major constituent isointermedeol induce apoptosis by increased expression of mitochondrial cytochrome c and apical death receptors in human leukaemia HL-60 cells.
Kumar A; Malik F; Bhushan S; Sethi VK; Shahi AK; Kaur J; Taneja SC; Qazi GN; Singh J
Chem Biol Interact; 2008 Feb; 171(3):332-47. PubMed ID: 18070620
[TBL] [Abstract][Full Text] [Related]
9. Ultrasmall gold-doxorubicin conjugates rapidly kill apoptosis-resistant cancer cells.
Zhang X; Chibli H; Mielke R; Nadeau J
Bioconjug Chem; 2011 Feb; 22(2):235-43. PubMed ID: 21189001
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression.
Notarbartolo M; Poma P; Perri D; Dusonchet L; Cervello M; D'Alessandro N
Cancer Lett; 2005 Jun; 224(1):53-65. PubMed ID: 15911101
[TBL] [Abstract][Full Text] [Related]
11. 18beta-Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity.
Lee CS; Kim YJ; Lee MS; Han ES; Lee SJ
Life Sci; 2008 Sep; 83(13-14):481-9. PubMed ID: 18721818
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
Gewirtz DA; Di X; Walker TD; Sawyer ST
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
[TBL] [Abstract][Full Text] [Related]
13. Proteinase-3, a serine protease which mediates doxorubicin-induced apoptosis in the HL-60 leukemia cell line, is downregulated in its doxorubicin-resistant variant.
Wu CH; Gordon J; Rastegar M; Ogretmen B; Safa AR
Oncogene; 2002 Aug; 21(33):5160-74. PubMed ID: 12140766
[TBL] [Abstract][Full Text] [Related]
14. 1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage.
Ravid A; Rocker D; Machlenkin A; Rotem C; Hochman A; Kessler-Icekson G; Liberman UA; Koren R
Cancer Res; 1999 Feb; 59(4):862-7. PubMed ID: 10029076
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis-inducing active components from Corbicula fluminea through activation of caspase-2 and production of reactive oxygen species in human leukemia HL-60 cells.
Huang YT; Huang YH; Hour TC; Pan BS; Liu YC; Pan MH
Food Chem Toxicol; 2006 Aug; 44(8):1261-72. PubMed ID: 16545898
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of some nitrogen containing steroidal heterocycles.
Abdelhalim MM; Kamel EM; Rabie ST; Mohamed NR
Steroids; 2011 Jan; 76(1-2):78-84. PubMed ID: 20849869
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation.
Koceva-Chyła A; Jedrzejczak M; Skierski J; Kania K; Jóźwiak Z
Apoptosis; 2005 Dec; 10(6):1497-514. PubMed ID: 16215684
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species.
Wagner BA; Buettner GR; Oberley LW; Burns CP
Cancer Res; 1998 Jul; 58(13):2809-16. PubMed ID: 9661895
[TBL] [Abstract][Full Text] [Related]
19. (Arene)Cl₂Ru(II) complexes with N-coordinated estrogen and androgen isonicotinates: interaction with sex hormone binding globulin and anticancer activity.
Schobert R; Seibt S; Effenberger-Neidnicht K; Underhill C; Biersack B; Hammond GL
Steroids; 2011 Mar; 76(4):393-9. PubMed ID: 21184767
[TBL] [Abstract][Full Text] [Related]
20. HPMA copolymers containing doxorubicin bound by a proteolytically or hydrolytically cleavable bond: comparison of biological properties in vitro.
Kovár M; Kovár L; Subr V; Etrych T; Ulbrich K; Mrkvan T; Loucká J; Ríhová B
J Control Release; 2004 Sep; 99(2):301-14. PubMed ID: 15380639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
